TARRYTOWN, N.Y., March 12 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere," Nasdaq: EMIS) announced today an addendum to its fourth quarter and year ended 2006 financial...
TARRYTOWN, N.Y., Jan. 16 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere", Nasdaq: EMIS) today announced that Michael M. Goldberg, M.D. Emisphere's Chief Executive Officer...
Company to Present Results Today During Presentation at Rodman and Renshaw Healthcare Conference TARRYTOWN, N.Y., Nov. 8 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere...
No Further Toxicology Studies are Planned for the NDA Submission of Oral Calcitonin TARRYTOWN, N.Y., May 25 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere", Nasdaq: EMIS...
Novartis Pharma AG elects to develop oral growth hormone using Emisphere's technology TARRYTOWN, N.Y., May 1 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere", Nasdaq: EMIS...
Emisphere Technologies to Hold Annual Shareholders Meeting on May 23, 2005 TARRYTOWN, N.Y., May 13 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. will host its annual shareholders...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales